Clinical Trials

Inclusion Criteria:

• Males or females ≥ 18 years of age.
• Patients with operable breast or lung cancer with tumors ≥ 1cm (according to imaging) prior to surgery not requiring neoadjuvant therapy.
• Histologically confirmed adenocarcinoma of the breast operable stage I-III or histologically confirmed carcinoma of the lung operable stage I-III will be enrolled prior to their definitive surgery.
• Patients must have adequate organ function, not receive systemic neoadjuvant therapy, and be willing to provide tissue, blood, and stool samples for research study.
• Patients must not have taken any probiotics in the past 30 days prior to the enrollment.

Exclusion Criteria:

• Patients < 18 years of age.
• Patients with autoimmune disease, immune deficiency such as HIV, irritable bowel, known diverticulosis, and other serious GI conditions at treating physician’s discretion will be excluded.

Eligibility last updated 1/12/22. Questions regarding updates should be directed to the study team contact.